Cargando…

Vaccines and Therapies in Development for SARS-CoV-2 Infections

The current COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. The virus causes severe respiratory symptoms which manifest disproportionately in the elderly. Currently, there are over 6.5 million cases and 380,000 deaths reported. Given the current severity of the outbreak, there is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, David, Koganti, Raghuram, Lambe, Upendra P., Yadavalli, Tejabhiram, Nandi, Shyam S., Shukla, Deepak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355822/ https://www.ncbi.nlm.nih.gov/pubmed/32560227 http://dx.doi.org/10.3390/jcm9061885

Ejemplares similares

Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
por: Koganti, Raghuram, et al.
Publicado: (2019)

In vitro protocol for the optimal induction of inflammation in human monocyte cell lines
por: Koganti, Raghuram, et al.
Publicado: (2023)

Immune Response to SARS-CoV-2 Vaccines
por: Bellamkonda, Navya, et al.
Publicado: (2022)

Herpes Simplex Virus Cell Entry Mechanisms: An Update
por: Madavaraju, Krishnaraju, et al.
Publicado: (2021)

Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation
por: Koganti, Raghuram, et al.
Publicado: (2022)

Dysregulation of Cell Signaling by SARS-CoV-2
por: Suryawanshi, Rahul K., et al.
Publicado: (2021)

Development of a RT-LAMP assay for detection of SARS-CoV-2
por: Nandi, Shyam Sundar, et al.
Publicado: (2022)

Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing
por: Yadavalli, Tejabhiram, et al.
Publicado: (2020)

BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2
por: Sutar, Yogesh, et al.
Publicado: (2021)

Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction
por: Suryawanshi, Rahul K., et al.
Publicado: (2023)

Aptamers in Virology—A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy
por: Yadavalli, Tejabhiram, et al.
Publicado: (2021)

Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry
por: Suryawanshi, Rahul K., et al.
Publicado: (2021)

mTORC2 confers neuroprotection and potentiates immunity during virus infection
por: Suryawanshi, Rahul K., et al.
Publicado: (2021)

Emerging Roles of Heparanase in Viral Pathogenesis
por: Thakkar, Neel, et al.
Publicado: (2017)

Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1
por: Bhattacharya, Ilina, et al.
Publicado: (2022)

Heparanase, cell signaling, and viral infections
por: Koganti, Raghuram, et al.
Publicado: (2020)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells
por: Yadavalli, Tejabhiram, et al.
Publicado: (2022)

An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine
por: Agelidis, Alex, et al.
Publicado: (2019)

Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection
por: Yadavalli, Tejabhiram, et al.
Publicado: (2017)

Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas
por: Duggal, Neil, et al.
Publicado: (2017)

Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer
por: Tiwari, Vaibhav, et al.
Publicado: (2021)

Unique Attributes of Guinea Pigs as New Models to Study Ocular Herpes Pathophysiology and Recurrence
por: Yadavalli, Tejabhiram, et al.
Publicado: (2023)

Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells
por: Thakkar, Neel, et al.
Publicado: (2017)

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Editorial: Ocular infection of herpes: Immunology, pathogenesis, and interventions
por: Yadavalli, Tejabhiram, et al.
Publicado: (2022)

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
por: Hudakova, Nikola, et al.
Publicado: (2021)

SARS-CoV-2 virus: Vaccines in development
por: Huang, Qingrui, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
por: McGill, Andrew R., et al.
Publicado: (2021)

Coronavirus (SARS-CoV-2): a systematic review for potential vaccines
por: Bhatta, Mihir, et al.
Publicado: (2021)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery
por: Yadavalli, Tejabhiram, et al.
Publicado: (2019)

OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection
por: Ames, Joshua, et al.
Publicado: (2021)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
por: Ma, Cuiqing, et al.
Publicado: (2020)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
por: Oves, Mohammad, et al.
Publicado: (2020)

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9dtl5t0bnphv9k205cbharhbl9